FOSTER CITY, Calif. (AP) — FOSTER CITY, Calif. (AP) — Gilead Sciences Inc. (GILD) on Tuesday reported fourth-quarter earnings of $1.78 billion.
The Foster City, California-based company said it had net income of $1.42 per share. Earnings, adjusted for one-time gains and costs, were $1.90 per share.
The results exceeded Wall Street expectations. The average estimate of 11 analysts surveyed by Zacks Investment Research was for earnings of $1.67 per share.
The HIV and hepatitis C drugmaker posted revenue of $7.57 billion in the period, also beating Street forecasts. Nine analysts surveyed by Zacks expected $7.06 billion.
Gilead expects full-year earnings in the range of $7.70 to $8.10 per share.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on GILD at https://www.zacks.com/ap/GILD
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.